September 19, 2005
SpeculatingStocks.com Stock Pick: Novavax, Inc. (NVAX)
Stock Price: $1.60 (long-term strong buy)
Novavax, Inc. is a specialty biopharmaceutical company focused on the research, development and commercialization of products utilizing its proprietary drug delivery and biological technologies for large and growing markets. The company currently distributes a line of prescription pharmaceutical products.
NVAX has been heating up as of late due to the development of a bird flu vaccine. Their vaccine has not yet been proven to work with humans, but has shown to protect animals in preclinical trials.
This company has created a new method called Virus-Like Particle technology for producing vaccines in larger quantity in less time. VLP technology is being used with the bird flu vaccine. VLP technological applications could go far beyond its current uses.
NVAX bottomed below $1.00 and is now moving higher on its highest volume ever.
SpeculatingStocks.com Target Price: We expect NVAX to reach $4.00 within the next 4 - 8 months.